Fennec Pharmaceuticals Inc (FENC) Net earnings per share growth forecast for next year

Corporate company logo of Fennec Pharmaceuticals (FENC)

Stable cash flow and financial stability at Fennec Pharmaceuticals (FENC) confirm the business's reliability. This chart of consensus EPS growth estimates for next year demonstrates positive momentum, with the 216.90 mark capturing this metric. Success is based on the implementation of PEDMARK and insurance coverage, as well as high physician confidence in unique methods for protecting children's hearing during cancer therapy.

Fennec Pharmaceuticals Inc (FENC): Net earnings per share growth forecast for next year from 07/04/2022 to 11/12/2026

Summary analytical data breakdowns for fennecpharma.com (FENC)

- share price and consensus valuation forecast:
Stock Price Fennec Pharmaceuticals Inc|FENC - Consensus Target
- market capitalization details:
Market Value Fennec Pharmaceuticals|FENC - Total Enterprise Value
- company book value details:
Net Assets per Single Share Fennec Pharmaceuticals|FENC - Company Book Value|Market Value to Book Value Ratio fennecpharma.com|FENC - Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Fennec Pharmaceuticals|FENC - Long-Term Indebtedness to Equity|Short-Term Debt to Equity Ratio Fennec Pharmaceuticals Inc.|FENC - Company Cumulative Debt|Debt to Book Value Fennec Pharmaceuticals|FENC - Company Long-Term Loans and Borrowings|Company Current Liabilities Fennec Pharmaceuticals|Quick Ratio fennecpharma.com
- net income and valuation ratios data:
FENC - Final Profit|Projected Future Earnings Fennec Pharmaceuticals|FENC - Market Cap to Earnings|Future Price to Earnings Fennec Pharmaceuticals|FENC - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Fennec Pharmaceuticals|FENC - Operating profit EBITDA|Earnings per share for the last twelve months Fennec Pharmaceuticals|FENC - Earnings per one share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months fennecpharma.com|FENC - Earnings per share growth rate in current year|Earnings growth forecast for next year Fennec Pharmaceuticals
Fundamental company analysis:Fennec Pharmaceuticals Inc
Finished products of Fennec Pharma

This indicator measures consolidated expert expectations regarding profit growth rates for the coming year, allowing market noise to be filtered out from the long-term trend. The forward-looking assessment of net income dynamics reflects the monetization potential of Fennec Pharmaceuticals (FENC) and its unique hearing protection drug for children. A monopoly position and patent protection ensure predictable cash flows. The company's high pricing power makes the projected profit growth resilient to market volatility.

Competitor analysis for Fennec Pharmaceuticals

INCY (Incyte Corp.) - Earnings growth forecast for next year|Expected earnings per share growth for next year HUTCHMED Corp (HCM)|Net earnings per share growth forecast for next year Nuvation Bio Inc. (NUVB)|DAWN - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Monopar Therapeutics Inc. MNPR|Inhibrx - Net earnings per share growth forecast for next year|IMAB - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Heron Therapeutics|NVCT: Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Coherus BioSciences CHRS|Expected earnings per share growth for next year CRBP|Expected net earnings per share growth next year Cardiff Oncology Corp CRDF|Expected earnings per share growth for next year BYSI (BeyondSpring Pharma)|BCAB (bioatla.com) - Expected earnings per share trend next year|Lixte Biotechnology - Expected earnings per share growth for next year|Projected earnings per share increase next year CTXR (Citius Pharmaceuticals Inc.)|Cellectar Biosciences, Inc. - Earnings growth forecast for next year|Expected earnings per share trend next year BLRX (BioLineRx Ltd)|CANF: Earnings growth forecast for next year|Expected net earnings per share growth next year Aprea Therapeutics, Inc. (APRE)|Net earnings per share growth forecast for next year Kazia Therapeutics Ltd|SLXN: Expected earnings per share trend next year|Earnings growth forecast for next year NCNA|Earnings growth forecast for next year Chimerix Inc. (CMRX)|Net earnings per share growth forecast for next year Cyclacel Pharmaceuticals Inc. CYCC|GTHX (G1 Therapeutics Inc.) - Net earnings per share change forecast for next year|KRON: Expected earnings per share growth for next year|Expected net earnings per share growth next year kintara.com|ONCT: Earnings growth forecast for next year|Net earnings per share change forecast for next year PRTG (Portage Biotech Inc)